[Prevention of therapeutic inertia in the treatment of arterial hypertension by using a program of home blood pressure monitoring]
- PMID: 22019112
- PMCID: PMC7025153
- DOI: 10.1016/j.aprim.2010.09.022
[Prevention of therapeutic inertia in the treatment of arterial hypertension by using a program of home blood pressure monitoring]
Abstract
Objective: To evaluate the efficacy of a program of home blood pressure monitoring (HBPM) on therapeutic Inertia (TI) in mild-to-moderate hypertension (AHT).
Design: Controlled, randomised clinical trial.
Setting: Forty six clinics in 35 primary care centres. Spain.
Participants: A total of 232 patients with uncontrolled hypertension were included.
Intervention: Two groups with 116 patients were formed: 1) Control group (CG): standard health intervention; 2) Intervention group (IG): patients who were included in the HBPM program.
Main measurements: TI was calculated by the ratio: Number of patients whose pharmacological treatment was not changed in each visit/Number of patients with an average BP 140mmHg and/or 90mmHg in the general population or 130 and/or 90 mmHg in diabetics. The mean BPs and the percentage of controlled patients were calculated. The mean number of people that required an intervention in order to avoid TI was calculated (NI).
Results: A total of 209 patients completed the study, with TI in 35.64% (95% CI=29.85%-41.43%) of the sample, and in 71.63% (95% CI=63.9-79.36%) of the uncontrolled hypertensive patients. The TI was 22.42% (95% CI=24.2-37%) in the IG and 50% (95% CI=37.75-62.25) in the CG (p<.05) in visit 2, and 25.23% (95% CI=14.84-35.62) and 46.07% (95% CI=33.85-58.29) in the final visit for IG and CG, respectively (P<.05). The NI was 4.3.
Conclusions: TI was very significant among the uncontrolled hypertensive patients. The studied interventions are effective for improving TI.
Objetivo: Evaluar si un programa de automedida domiciliaria de presión arterial (AMPA) es eficaz para obtener una menor inercia terapéutica (IT) en el tratamiento de la HTA.
Diseño: Estudio clínico controlado, aleatorizado y multicéntrico.
Emplazamiento: 35 centros de salud de España.
Participantes: Se incluyeron 232 hipertensos.
Intervención: Se formaron 2 grupos con 116 individuos: 1, grupo de control (GC): recibieron la intervención habitual; 2, grupo de intervención: se inscribieron en un programa de AMPA.
Mediciones principales: La IT se midió mediante el cociente: (Número de pacientes sin modificación del tratamiento farmacológico en cada visita / Número de pacientes con cifras medias de PA ≥ 140 mmHg y/o ≥ 90 mmHg en población general o ≥ 130 y/o 80 mmHg en diabéticos) y multiplicado por 100. Se calculó la IT por visitas, las PA medias y grado de control de la HTA.
Resultados: Concluyeron 209 individuos (edad media 69,28 ± 11,6 años) (p = NS por grupos) (GI 107 individuos y GC 102).
La IT fue 35,64% de las visitas de la muestra (IC = 29,85-41,43%) y en el 71,63% (IC = 63,9-79,36%) en hipertensos no controlados.
La IT fue del 22,42% (IC = 24,2-37%) en el GI y 50% (IC = 37,75-62,25) en el GC (p < 0,05) en visita 2, y del 25,23% (IC = 14,84-35,62) y 46,07% (IC = 33,85-58,29) en visita final para GI y GC respectivamente (p < 0,05).
Conclusiones: La IT ha sido muy relevante. El programa de AMPA es eficaz para obtener una menor IT.
Copyright © 2010 Elsevier España, S.L. All rights reserved.
Figures
Similar articles
-
[Control of therapeutic inertia in the treatment of arterial hypertension by using different strategies].Aten Primaria. 2009 Jun;41(6):315-23. doi: 10.1016/j.aprim.2008.09.017. Epub 2009 May 31. Aten Primaria. 2009. PMID: 19482378 Free PMC article. Clinical Trial. Spanish.
-
Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study.J Hypertens. 2006 Jan;24(1):169-75. doi: 10.1097/01.hjh.0000198023.53859.a2. J Hypertens. 2006. PMID: 16331115 Clinical Trial.
-
[A specific questionnaire to evaluate therapeutic inertia in hypertensive patients: a pilot study].J Mal Vasc. 2014 Feb;39(1):4-13. doi: 10.1016/j.jmv.2013.09.001. Epub 2013 Oct 8. J Mal Vasc. 2014. PMID: 24119421 French.
-
Implementing Home Blood Pressure Monitoring into Clinical Practice.Curr Hypertens Rep. 2019 Feb 12;21(2):14. doi: 10.1007/s11906-019-0916-0. Curr Hypertens Rep. 2019. PMID: 30747350 Review.
-
Does This Adult Patient Have Hypertension?: The Rational Clinical Examination Systematic Review.JAMA. 2021 Jul 27;326(4):339-347. doi: 10.1001/jama.2021.4533. JAMA. 2021. PMID: 34313682
References
-
- Okonofua E.C., Simpson K.N., Jesri A., Rehman S.U., Durkalski V.L., Egan B.M. Therapeutic inertia is an impediment to achieving the Healthy People 2010. Blood pressure control goals. Hypertension. 2006;47:345–351. - PubMed
-
- Márquez Contreras E., Martín de Pablos J.L., Gil Guillén V., Martell Claros N., Motero Carrasco J., Casado Martínez J.J. La inercia clínica profesional y el incumplimiento farmacológico. ¿Cómo influyen en el control de la HTA? Estudio Cumampa. Hipertensión. 2008;25:187–193.
-
- Phillips L.S., Branch W.T., Cook C.B., Doyle J.P., El-Kebbi I.M., Gallina D.L. Clinical inertia. Ann Intern Med. 2001;135:825–834. - PubMed
-
- Faria C., Wenzel M., Lee K.W., Coderre K., Nichols J., Belletti D.A. A narrative review of clinical inertia:focus on hypertension. J Am Soc Hypertens. 2009;3:267–276. - PubMed
-
- De la Figuera Von Wichmann M. Sanidad y Ediciones S.L; Madrid: 2008. Inercia terapéutica. p. 1–40.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical